
OPKO Health OPK
€ 0.99
-0.43%
Quartalsbericht 2025-Q2
hinzugefügt 31.07.2025
OPKO Health DPO 2011-2026 | OPK
DPO Jährlich OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.1 | 45.7 | 38 | - | - | 39.9 | 28.6 | 43.7 | 31.9 | 113 | 66.5 | 100 | 134 | 104 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 134 | 28.6 | 65.6 |
DPO Vierteljährlich OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.3 | 51.9 | - | 53.6 | 47.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 459 | 359 | - | 71.8 | 63.5 | 81.6 | - | 102 | 93.4 | 91.6 | - | 124 | 142 | 138 | - | 111 | 91.3 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 459 | 47.8 | 125 |
DPO anderer Aktien in der Diagnostik & Forschung
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
50.1 | $ 115.38 | 0.26 % | $ 35.1 B | ||
|
BioNano Genomics
BNGO
|
149 | $ 1.13 | - | $ 6.15 M | ||
|
Burning Rock Biotech Limited
BNR
|
125 | $ 15.65 | -2.86 % | $ 168 M | ||
|
Aspira Women's Health
AWH
|
189 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 16.19 | 0.87 % | $ 863 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
4.24 K | $ 1.38 | 0.36 % | $ 1.84 M | ||
|
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | ||
|
Interpace Biosciences
IDXG
|
33 | $ 2.3 | - | $ 10.2 M | ||
|
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
52 | $ 23.22 | 0.39 % | $ 645 M | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 174.38 | -0.74 % | $ 8.64 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
13.3 | $ 498.0 | 0.91 % | $ 14.4 B | ||
|
Danaher Corporation
DHR
|
65.4 | $ 189.16 | -0.22 % | $ 135 B | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
56.3 | $ 121.65 | 0.6 % | $ 19.3 B | ||
|
Myriad Genetics
MYGN
|
45.9 | $ 4.37 | 0.34 % | $ 405 M | ||
|
NeoGenomics
NEO
|
19.7 | $ 7.79 | 1.3 % | $ 998 M | ||
|
Fulgent Genetics
FLGT
|
34.9 | $ 14.67 | 1.66 % | $ 444 M | ||
|
Guardant Health
GH
|
48.6 | $ 79.04 | 0.55 % | $ 9.91 B | ||
|
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
1.29 K | $ 2.73 | 1.49 % | $ 88.6 K | ||
|
Biomerica
BMRA
|
32.4 | $ 2.08 | -2.8 % | $ 4.78 M | ||
|
Invitae Corporation
NVTA
|
69 | - | - | $ 21.2 M | ||
|
ICON Public Limited Company
ICLR
|
6.52 | $ 107.7 | 0.83 % | $ 8.88 B | ||
|
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 260.87 | -0.02 % | $ 21.7 B | ||
|
Natera
NTRA
|
17.9 | $ 196.81 | 1.96 % | $ 19.4 B | ||
|
Lantheus Holdings
LNTH
|
23.6 | $ 80.04 | -0.68 % | $ 5.4 B | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | ||
|
Senseonics Holdings
SENS
|
68 | $ 6.54 | -2.1 % | $ 273 M | ||
|
Quest Diagnostics Incorporated
DGX
|
14.7 | $ 191.24 | -0.15 % | $ 21.2 B | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 9.16 | -2.79 % | $ 1.99 B | ||
|
Soleno Therapeutics
SLNO
|
1.44 K | $ 52.56 | -0.13 % | $ 2.67 B | ||
|
ENDRA Life Sciences
NDRA
|
1.65 K | $ 5.0 | 1.21 % | $ 3.94 M | ||
|
Organovo Holdings
ONVO
|
82.9 K | - | -2.3 % | $ 19.4 M |